Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Guruprasad Varma Konduru & Hampapathalu Adimurthy Nagarajaram. (2023) Human TMPRSS2 non-catalytic ectodomain and SARS-CoV-2 S2' subunit interaction mediated SARS-CoV-2 endocytosis: a model proposal with virtual screening for potential drug molecules to inhibit this interaction. Journal of Biomolecular Structure and Dynamics 41:13, pages 6422-6433.
Read now
Read now
Yan A. Ivanenkov, Vladimir A. Aladinskiy, Nikolay A. Bushkov, Andrey A. Ayginin, Alexander G. Majouga & Alexandre V. Ivachtchenko. (2017) Small-molecule inhibitors of hepatitis C virus (HCV) non-structural protein 5A (NS5A): a patent review (2010-2015). Expert Opinion on Therapeutic Patents 27:4, pages 401-414.
Read now
Read now
Annarosa Floreani. (2015) Perspectives of fixed daily dose of sofosbuvir and ledipasvir for the treatment of chronic hepatitis C. Expert Opinion on Pharmacotherapy 16:6, pages 801-804.
Read now
Read now
Articles from other publishers (11)
Shivam Chowdhary, Rahul Deka, Kingshuk Panda, Rohit Kumar, Abhishikt David Solomon, Jimli Das, Supriya Kanoujiya, Ashish Kumar Gupta, Somya Sinha, Janne Ruokolainen, Kavindra Kumar Kesari & Piyush Kumar Gupta. (2023) Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities. Molecular Pharmaceutics 20:8, pages 3698-3740.
Crossref
Crossref
Zhiguo Wang & Baofeng YangZhiguo Wang & Baofeng Yang. 2022. Polypharmacology. Polypharmacology
301
321
.
Andrey V. Smolobochkin, Rakhymzhan A. Turmanov, Almir S. Gazizov, Elizaveta A. Kuznetsova, Alexander R. Burilov & Mikhail A. Pudovik. (2020) Synthesis of Novel 2-Hetarylpyrrolidines via the Reaction of N-(4,4-diethoxybutyl)amidophosphates with C-nucleophiles. Chemistry of Heterocyclic Compounds 56:10, pages 1363-1365.
Crossref
Crossref
Ameer Abutaleb, Shyam Kottilil & Eleanor Wilson. (2018) Glecaprevir/pibrentasvir expands reach while reducing cost and duration of hepatitis C virus therapy. Hepatology International 12:3, pages 214-222.
Crossref
Crossref
Rebecca Lee, Shyam Kottilil & Eleanor Wilson. (2016) Sofosbuvir/velpatasvir: a pangenotypic drug to simplify HCV therapy. Hepatology International 11:2, pages 161-170.
Crossref
Crossref
Yi Li, Qing-Zhu Li, Li Huang, Hong Liang, Kai-Chuan Yang, Hai-Jun Leng, Yue Liu, Xu-Dong Shen, Xiao-Jun Gou & Jun-Long Li. (2017) Diastereoselective Synthesis of Spirocyclopropanes under Mild Conditions via Formal [2 + 1] Cycloadditions Using 2,3-Dioxo-4-benzylidene-pyrrolidines. Molecules 22:2, pages 328.
Crossref
Crossref
A. Ferreira-Gonzalez. 2017. Diagnostic Molecular Pathology. Diagnostic Molecular Pathology
485
501
.
N.A. Meanwell. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
553
627
.
Nannan Zhou, Zhou Han, Sandra Hartman-Neumann, Brenda DeGray, Joseph Ueland, Vincent Vellucci, Dennis Hernandez & Fiona McPhee. (2016) Characterization of NS5A polymorphisms and their impact on response rates in patients with HCV genotype 2 treated with daclatasvir-based regimens. Journal of Antimicrobial Chemotherapy 71:12, pages 3495-3505.
Crossref
Crossref
Nicholas A. Meanwell. (2016) 2015 Philip S. Portoghese Medicinal Chemistry Lectureship. Curing Hepatitis C Virus Infection with Direct-Acting Antiviral Agents: The Arc of a Medicinal Chemistry Triumph. Journal of Medicinal Chemistry 59:16, pages 7311-7351.
Crossref
Crossref
Chenwei Pan, Yongping Chen, Weilai Chen, Guangyao Zhou, Lingxiang Jin, Yi Zheng, Wei Lin & Zhenzhen Pan. (2016) Simultaneous determination of ledipasvir, sofosbuvir and its metabolite in rat plasma by UPLC–MS/MS and its application to a pharmacokinetic study. Journal of Chromatography B 1008, pages 255-259.
Crossref
Crossref